Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $30.00 Analyst target: $29.26 Upside: -2.47%
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.
See the full interactive analysis & chart →Informational only — not investment advice.